Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span H Vaziri, S Benchimol Current Biology 8 (5), 279-282, 1998 | 1349 | 1998 |
p53: oncogene or anti-oncogene DP Lane, S Benchimol Genes Dev 4 (1), 1-8, 1990 | 1172 | 1990 |
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation RP Leng, Y Lin, W Ma, H Wu, B Lemmers, S Chung, JM Parant, G Lozano, ... Cell 112 (6), 779-791, 2003 | 954 | 2003 |
ATM‐dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post‐translational activation of p53 protein involving poly (ADP‐ribose) polymerase H Vaziri, MD West, RC Allsopp, TS Davison, YS Wu, CH Arrowsmith, ... The EMBO journal, 1997 | 513 | 1997 |
Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis Y Lin, W Ma, S Benchimol Nature genetics 26 (1), 122-127, 2000 | 487 | 2000 |
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus M Mowat, A Cheng, N Kimura, A Bernstein, S Benchimol Nature 314 (6012), 633-636, 1985 | 456 | 1985 |
Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. H Ahuja, M Bar-Eli, SH Advani, S Benchimol, MJ Cline Proceedings of the National Academy of Sciences 86 (17), 6783-6787, 1989 | 404 | 1989 |
p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest JSL Ho, W Ma, DYL Mao, S Benchimol Molecular and cellular biology 25 (17), 7423-7431, 2005 | 361 | 2005 |
p53-dependent pathways of apoptosis S Benchimol Cell death and differentiation 8 (11), 1049-1051, 2001 | 301 | 2001 |
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy RG Bristow, S Benchimol, RP Hill Radiotherapy and oncology 40 (3), 197-223, 1996 | 295 | 1996 |
Transcriptional repression mediated by the p53 tumour suppressor. J Ho, S Benchimol Cell Death & Differentiation 10 (4), 2003 | 280 | 2003 |
Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. VR Prideaux, V Chow, S Benchimol, A Bernstein Oncogene 3 (2), 179-185, 1988 | 225 | 1988 |
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. B Rovinski, S Benchimol Oncogene 2 (5), 445-452, 1988 | 211 | 1988 |
ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress W Assaily, DA Rubinger, K Wheaton, Y Lin, W Ma, W Xuan, ... Molecular cell 44 (3), 491-501, 2011 | 196 | 2011 |
Expression of Wild-Type p53 Is Not Compatible with-Continued Growth of p53-Negative Tumor Cells P Johnson, D Gray, M Mowat, S Benchimol Molecular and cellular biology, 1991 | 192 | 1991 |
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin P Johnson, S Chung, S Benchimol Molecular and Cellular Biology 13 (3), 1456-1463, 1993 | 183 | 1993 |
The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53. RL Zastawny, R Salvino, J Chen, S Benchimol, V Ling Oncogene 8 (6), 1529-1535, 1993 | 173 | 1993 |
Transformation associated p53 protein is encoded by a gene on human chromosome 17 S Benchimol, P Lamb, LV Crawford, D Sheer, TB Shows, GAP Bruns, ... Somatic cell and molecular genetics 11, 505-510, 1985 | 169 | 1985 |
Mutation of the p53 gene in human acute myelogenous leukemia JM Slingerland, MD Minden, S Benchimol | 157 | 1991 |
Participation of the human p53 3′ UTR in translational repression and activation following γ‐irradiation L Fu, S Benchimol The EMBO journal, 1997 | 152 | 1997 |